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Histamine dehydrogenase (HADH) from Nocardioides simplex catalyzes the
oxidative deamination of histamine to produce imidazole acetaldehyde and an
ammonium ion. HADH is functionally related to trimethylamine dehydro-
genase (TMADH), but HADH has strict substrate specificity towards histamine.
HADH is a homodimer, with each 76 kDa subunit containing two redox
cofactors: a [4Fe–4S] cluster and an unusual covalently bound flavin
mononucleotide, 6-S-cysteinyl-FMN. In order to understand the substrate
specificity of HADH, it was sought to determine its structure by X-ray
crystallography. This enzyme has been expressed recombinantly in Escherichia
coli and successfully crystallized in two forms. Diffraction data were collected to
2.7 Å resolution at the SSRL synchrotron with 99.7% completeness. The crystals
belonged to the orthorhombic space group P212121, with unit-cell parameters
a = 101.14, b = 107.03, c = 153.35 Å.
1. Introduction
Histamine is an essential biogenic amine that is present in prokary-
otes and the tissues of animals and plants. In humans, histamine acts
as a neurotransmitter, mediates allergic reactions, plays a role in cell
proliferation and is important in signaling the release of gastric acid
into the stomach (Thurmond et al., 2008). Histamine receptors are the
targets of drugs that treat allergies and stomach acidity, but there is
very little structural information on the histamine-binding sites of
these proteins. Thus, model systems may prove useful for under-
standing histamine binding (Konkimalla & Chandra, 2003).
Histamine dehydrogenase (HADH) from Nocardioides simplex
catalyzes the oxidative deamination of histamine to form imidazole
acetaldehyde and an ammonium ion (Fig. 1). HADH (Fujieda et al.,
2004; Limburg et al., 2005) is related to trimethylamine dehydro-
genase (TMADH; EC 1.5.99.7; McIntire, 1990; Steenkamp, Kenney et
al., 1978; Steenkamp, McIntire et al., 1978), which contains a 6-S-
cysteinyl FMN and a [4Fe–4S] cluster. HADH differs from TMADH
in its substrate specificity. TMADH acts on short secondary and
tertiary amines. In contrast, HADH is selective for the primary amine
substrates histamine (Km = 31 mM, kcat/Km = 2.1  10
5 M1 s1),
agmatine or decarboxylated arginine (Km = 37 mM, kcat/Km = 6.0 
104 M1 s1) and putrescine or butane-1,4-diamine (Km = 1280 mM,
kcat/Km = 1500 M
1 s1) (Limburg et al., 2005). The selectivity for
histamine over other biogenic amines suggests that HADH could be
used in an amperometric biosensor. Current methods for histamine
detection rely on either radioenzymatic or HLPC-based derivatiza-
tion. The structural determination of HADH, with its unique selec-
tivity for histamine, could prove useful in the design of a histamine
biosensor and provide important insights into histamine recognition
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Figure 1
Histamine-deamination reaction catalyzed by HADH.
by proteins. Furthermore, comparison of the structures of HADH
and TMADH may provide insights into the mechanism of this class of
enzymes, particularly in regard to the substrate-binding site and the
electronic interactions between the two cofactors.
2. Materials and methods
2.1. Cloning and expression
The hadh gene was cloned from genomic DNA of N. simplex
(ATCC 6946). PCR primers were designed to amplify the 2.1 kbp
fragment and incorporate EcoRI and XbaI sites for subsequent
insertion into pUC19. The resulting hadh gene was sequenced in the
forward and reverse directions and then subcloned between the NdeI
and EcoRI sites of pET21b (Novagen) in order to express the
recombinant protein without the C-terminal T7 tag or the N-terminal
His tag. The plasmid was transformed into Escherichia coli Rosetta 2
(DE3) cells (Novagen). The cells were grown in 1 l Terrific Broth
medium with 100 mg l1 ampicillin at 310 K and shaking at
225 rev min1 to an OD600 of 0.7. Protein expression was induced
with 0.1 mM isopropyl -d-1-thiogalactopyranoside. The addition of
250 mg l1 iron sulfate and 50 mg l1 riboflavin was also performed at
an OD600 of 0.7 in order to ensure full incorporation of the iron–
sulfur cluster and flavin mononucleotide. The temperature was
reduced to 293 K and the cultures were shaken at 225 rev min1
overnight. The cells were harvested by centrifugation at 277 K.
Selenomethionine-substituted protein was produced using the
methionine-auxotrophic E. coli strain B834 (DE3) (Novagen;
Doublié, 1997).
2.2. Purification
Cells (10 g) were resuspended in 20 mM potassium phosphate
buffer pH 7.4 containing 0.1 M KCl. Cells were disrupted by ultra-
sonication and centrifuged at 40 000g for 30 min. The supernatant
was loaded onto a 100 ml Toyopearl-DEAE column pre-equilibrated
with 20 mM potassium phosphate pH 7.4 containing 0.1 M KCl and
proteins were eluted with a 300 ml linear gradient increasing from 0.1
to 0.3 M KCl (20 mM potassium phosphate buffer pH 7.4). Fractions
exhibiting an Abs444/Abs382 ratio of 1.0 or higher were pooled and
ammonium sulfate was added to a final concentration of 0.8 M. The
protein solution was then loaded onto a 100 ml Toyopearl Butyl-650
column (Tosoh Bioscience) pre-equilibrated with 50 mM potassium
phosphate buffer pH 7.4 containing 0.8 M ammonium sulfate. Bound
proteins were eluted with a 300 ml gradient decreasing from 0.8 to
0 M ammonium sulfate (50 mM potassium phosphate buffer pH 7.4).
Fractions exhibiting an Abs444/Abs382 ratio of 1.2 or higher were
pooled and concentrated to 1 ml using an Amicon Ultra centrifugal
unit (Millipore). This protein was loaded onto a HiLoad Superdex
200 16/60 sizing column (GE Healthcare) and eluted with 50 mM
Tris–HCl pH 7.4 containing 0.15 M KCl. Fractions with an Abs444/
Abs382 ratio of 1.38 or higher were concentrated to >20 mg ml
1. The
purity of HADH was confirmed by SDS–PAGE and the protein
concentration was determined using a BCA assay (Thermo Fisher
Scientific). The kcat and Km for histamine were determined to be
9.8 s1 and 24 mM, respectively, using a standard assay (Siddiqui et al.,
2000). Selenomethionine-substituted protein was purified as
described above and the incorporation of selenomethionine was
determined by MALDI–TOF mass spectrometry at KU Analytical
Proteomics Laboratory.
2.3. Crystallization
Prior to crystallization, the protein was concentrated to 20 mg ml1
in 50 mM Tris–HCl buffer pH 7.4 containing 0.15 M KCl. Screening
to identify crystallization conditions was performed by the hanging-
drop vapor-diffusion method using commercially available sparse-
matrix screening kits (Hampton Research and Emerald Biosystems).
Equal volumes of protein and reservoir solution (1 ml + 1 ml) were
mixed and equilibrated against 750 ml reservoir solution at 293 K.
2.4. Data collection and processing
Initial unsubstituted HADH crystals were screened for X-ray
diffraction in-house on an R-AXIS IV++ detector with Cu K X-rays
generated by a Rigaku RU-H3RHB rotating-anode generator and
focused using an Osmic confocal optical system (Rigaku, Japan) at
KU Protein Structure Laboratory. A full data set was collected, but
initial attempts at molecular replacement using the TMADH struc-
ture (PDB code 1djn; Trickey et al., 2000) as a search model were not
successful. Subsequently, SeMet-HADH crystals were screened and a
complete MAD data set was collected on beamline BL9-2 at the
Stanford Synchrotron Radiation Laboratory (SSRL) using the
Stanford Automated Mounting (SAM) system (Cohen et al., 2002).
Data collection was performed at 100 K using an oscillation angle of
1 per frame over a total of 270 to yield a redundant data set. The
diffraction data were processed with MOSFLM (Leslie, 2006) and
scaled with SCALA from the CCP4 program suite (Collaborative
Computational Project, Number 4, 1994).
3. Results and discussion
3.1. Expression, flavin content, SeMet incorporation and purity
Recombinant unsubstituted HADH was overexpressed in E. coli
BL21 (DE3) Rosetta strain. The Rosetta strain was used as hadh has
a high GC content (>85%) with a number of rare codons in the
sequence. Expression using this system yielded 25 mg purified
protein per litre of of E. coli culture. Expression in the methionine-
auxotrophic E. coli strain B834 (DE3) reduced the yield to 1/10 of
that obtained using Rosetta expression. In order to ensure that the
resulting enzyme had a full content of 6-S-cysteinyl-FMN and [4Fe–
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Figure 2
Crystals of unsubstituted recombinant HADH grown in 0.1 M HEPES buffer pH
7.4 containing 2.0 M ammonium sulfate, 2%(v/v) PEG 400 and 4%(v/v) glycerol.
The crystal to the left is a square rod like those used to collect data, while the crystal
on the right is one of the square ‘pizza-box’ crystals viewed edge-on.
4S], the media were supplemented with the precursors of both
cofactors. The percentage of flavination can be determined from the
visible spectrum, in which an Abs444/Abs382 ratio of 1.4 is consistent
with a full complement of 6-S-cysteinyl-FMN (Fujieda et al., 2004).
Both unsubstituted and SeMet-HADH protein had ratios that were
above 1.37. MALDI–TOF mass spectrometry suggested that ten of
the 13 methionines were substituted. The recombinant HADH had
the same activity towards histamine (both kcat and kcat/Km) as the
native enzyme. As estimated by SDS–PAGE, recombinant HADH
had the expected molecular weight of 76 kDa and was purified
to >99% homogeneiety.
3.2. Crystallization
Initial yellow crystals grew as both square rods and square ‘pizza-
box’ crystals in 4–7 d in 0.1 M HEPES buffer pH 7.4 containing 2.0 M
ammonium sulfate and 2%(v/v) PEG 400 (Fig. 2). The growth of
these crystals was then optimized using the same solution, except the
protein concentration was varied from 5 to 20 mg ml1. These crystals
dissolved rapidly upon opening the sealed wells, but crystallization in
the same buffer with the addition of 2–4%(v/v) glycerol obviated this
problem and allowed harvesting of diffraction-quality crystals. The
crystals used for data collection were square rods that grew to
approximately 0.05  0.05  0.8 mm in size. We determined that a
solution consisting of mother liquor with the addition of 25% glycerol
was sufficient for cryoprotection of these crystals.
3.3. Data collection and preliminary X-ray diffraction analysis
Although we collected a complete three-wavelength MAD data
set, structure determination using SOLVE/RESOLVE was not
immediately successful. However, using only the single-wavelength
0.98 Å data, we were able to determine the structure by molecular
replacement using the polypeptide of TMADH from Methylophilus
methylotrophus (PDB code 1djn; Trickey et al., 2000) as a search
model and the program Phaser (LLG > 1012; McCoy et al., 2007). The
X-ray diffraction data used to solve the HADH structure were
collected to a resolution of 2.7 Å (Fig. 3) with 99.7% completeness
and an Rmerge of 16% (Table 1). The crystals belong to the ortho-
rhombic space group P212121, with unit-cell parameters a = 101.14,
b = 107.03, c = 153.35 Å. Each asymmetric unit contained two
molecules of HADH with a calculated Matthews coefficient VM of
2.79 Å3 Da1, giving an estimated solvent content of 55.96%
(Matthews, 1968). Refinement and model building are currently
ongoing using REFMAC (Murshudov et al., 1997) and Coot (Emsley
& Cowtan, 2004).
Home-source X-ray data were collected at the Protein Structure
Laboratory at The University of Kansas. High-resolution data were
collected at the Stanford Synchrotron Radiation Laboratory (SSRL),
which provided excellent diffraction facilities and support. The SSRL
is operated by the Department of Energy, Office of Basic Energy
Sciences. The SSRL Biotechnology Program is supported by the
National Institutes of Health, National Center for Research
Resources, Biomedical Technology Program and by the Department
of Energy, Office of Biological and Environmental Research. This
research was supported by NIH GM079446 (JL), NIH 5P20 RR17708
(COBRE Center in Protein Structure and Function) and funds from
the University of Kansas Center for Research.
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Figure 3
Diffraction pattern of HADH obtained on beamline BL9-2, SSRL. The resolution
of this data set was 2.7 Å.
Table 1
X-ray data-collection statistics for HADH.
Values in parentheses are for the last resolution shell.
Space group P212121
Unit-cell parameters (Å) a = 101.14, b = 107.03, c = 153.35
Resolution (Å) 84.5–2.70 (2.77–2.70)
No. of measurements 451076
No. of unique reflections 46309
Redundancy 9.7 (9.2)
Completeness (%) 99.7 (98.8)
Rmerge (%) 16.0 (38.5)
Average I/(I) 16.8 (6.3)
